Global DNA Diagnostics & Testing Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI09245946

Publication Date:

September 11, 2024

Pages:

117

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global DNA Diagnostics & Testing market size was valued at US$ 10040 million in 2023. With growing demand in downstream market, the DNA Diagnostics & Testing is forecast to a readjusted size of US$ 9892 million by 2030 with a CAGR of -0.2% during review period.
The research report highlights the growth potential of the global DNA Diagnostics & Testing market. DNA Diagnostics & Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of DNA Diagnostics & Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the DNA Diagnostics & Testing market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on DNA Diagnostics & Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the DNA Diagnostics & Testing market. It may include historical data, market segmentation by Type (e.g., PCR Based Diagnostics, NGS DNA Diagnosis), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the DNA Diagnostics & Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the DNA Diagnostics & Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the DNA Diagnostics & Testing industry. This include advancements in DNA Diagnostics & Testing technology, DNA Diagnostics & Testing new entrants, DNA Diagnostics & Testing new investment, and other innovations that are shaping the future of DNA Diagnostics & Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the DNA Diagnostics & Testing market. It includes factors influencing customer ' purchasing decisions, preferences for DNA Diagnostics & Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the DNA Diagnostics & Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting DNA Diagnostics & Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the DNA Diagnostics & Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the DNA Diagnostics & Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the DNA Diagnostics & Testing market.
Market Segmentation:
DNA Diagnostics & Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
PCR Based Diagnostics
NGS DNA Diagnosis
In-situ Hybridization Diagnostics
Micro-arrays Based Diagnostics
Segmentation by application
Oncology Diagnostics & Histopathology
Identity Diagnostics & Forensics
Pharmacogenomics Diagnostic Testing & Drug Metabolism
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Affymetrix Inc.
Agilent Technologies Inc
Applied Biosystems Group
Illumina Inc.
Cepheid Inc.
Hologic
Bio-Rad Laboratories
Dako
Abbott
Roche Diagnostics
Beckman Coulter Inc.
Siemens Healthcare

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global DNA Diagnostics & Testing Market Size 2019-2030
2.1.2 DNA Diagnostics & Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 DNA Diagnostics & Testing Segment by Type
2.2.1 PCR Based Diagnostics
2.2.2 NGS DNA Diagnosis
2.2.3 In-situ Hybridization Diagnostics
2.2.4 Micro-arrays Based Diagnostics
2.3 DNA Diagnostics & Testing Market Size by Type
2.3.1 DNA Diagnostics & Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global DNA Diagnostics & Testing Market Size Market Share by Type (2019-2024)
2.4 DNA Diagnostics & Testing Segment by Application
2.4.1 Oncology Diagnostics & Histopathology
2.4.2 Identity Diagnostics & Forensics
2.4.3 Pharmacogenomics Diagnostic Testing & Drug Metabolism
2.5 DNA Diagnostics & Testing Market Size by Application
2.5.1 DNA Diagnostics & Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global DNA Diagnostics & Testing Market Size Market Share by Application (2019-2024)
3 DNA Diagnostics & Testing Market Size by Player
3.1 DNA Diagnostics & Testing Market Size Market Share by Players
3.1.1 Global DNA Diagnostics & Testing Revenue by Players (2019-2024)
3.1.2 Global DNA Diagnostics & Testing Revenue Market Share by Players (2019-2024)
3.2 Global DNA Diagnostics & Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DNA Diagnostics & Testing by Regions
4.1 DNA Diagnostics & Testing Market Size by Regions (2019-2024)
4.2 Americas DNA Diagnostics & Testing Market Size Growth (2019-2024)
4.3 APAC DNA Diagnostics & Testing Market Size Growth (2019-2024)
4.4 Europe DNA Diagnostics & Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa DNA Diagnostics & Testing Market Size Growth (2019-2024)
5 Americas
5.1 Americas DNA Diagnostics & Testing Market Size by Country (2019-2024)
5.2 Americas DNA Diagnostics & Testing Market Size by Type (2019-2024)
5.3 Americas DNA Diagnostics & Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC DNA Diagnostics & Testing Market Size by Region (2019-2024)
6.2 APAC DNA Diagnostics & Testing Market Size by Type (2019-2024)
6.3 APAC DNA Diagnostics & Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe DNA Diagnostics & Testing by Country (2019-2024)
7.2 Europe DNA Diagnostics & Testing Market Size by Type (2019-2024)
7.3 Europe DNA Diagnostics & Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa DNA Diagnostics & Testing by Region (2019-2024)
8.2 Middle East & Africa DNA Diagnostics & Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa DNA Diagnostics & Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global DNA Diagnostics & Testing Market Forecast
10.1 Global DNA Diagnostics & Testing Forecast by Regions (2025-2030)
10.1.1 Global DNA Diagnostics & Testing Forecast by Regions (2025-2030)
10.1.2 Americas DNA Diagnostics & Testing Forecast
10.1.3 APAC DNA Diagnostics & Testing Forecast
10.1.4 Europe DNA Diagnostics & Testing Forecast
10.1.5 Middle East & Africa DNA Diagnostics & Testing Forecast
10.2 Americas DNA Diagnostics & Testing Forecast by Country (2025-2030)
10.2.1 United States DNA Diagnostics & Testing Market Forecast
10.2.2 Canada DNA Diagnostics & Testing Market Forecast
10.2.3 Mexico DNA Diagnostics & Testing Market Forecast
10.2.4 Brazil DNA Diagnostics & Testing Market Forecast
10.3 APAC DNA Diagnostics & Testing Forecast by Region (2025-2030)
10.3.1 China DNA Diagnostics & Testing Market Forecast
10.3.2 Japan DNA Diagnostics & Testing Market Forecast
10.3.3 Korea DNA Diagnostics & Testing Market Forecast
10.3.4 Southeast Asia DNA Diagnostics & Testing Market Forecast
10.3.5 India DNA Diagnostics & Testing Market Forecast
10.3.6 Australia DNA Diagnostics & Testing Market Forecast
10.4 Europe DNA Diagnostics & Testing Forecast by Country (2025-2030)
10.4.1 Germany DNA Diagnostics & Testing Market Forecast
10.4.2 France DNA Diagnostics & Testing Market Forecast
10.4.3 UK DNA Diagnostics & Testing Market Forecast
10.4.4 Italy DNA Diagnostics & Testing Market Forecast
10.4.5 Russia DNA Diagnostics & Testing Market Forecast
10.5 Middle East & Africa DNA Diagnostics & Testing Forecast by Region (2025-2030)
10.5.1 Egypt DNA Diagnostics & Testing Market Forecast
10.5.2 South Africa DNA Diagnostics & Testing Market Forecast
10.5.3 Israel DNA Diagnostics & Testing Market Forecast
10.5.4 Turkey DNA Diagnostics & Testing Market Forecast
10.5.5 GCC Countries DNA Diagnostics & Testing Market Forecast
10.6 Global DNA Diagnostics & Testing Forecast by Type (2025-2030)
10.7 Global DNA Diagnostics & Testing Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories DNA Diagnostics & Testing Product Offered
11.1.3 Abbott Laboratories DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Affymetrix Inc.
11.2.1 Affymetrix Inc. Company Information
11.2.2 Affymetrix Inc. DNA Diagnostics & Testing Product Offered
11.2.3 Affymetrix Inc. DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Affymetrix Inc. Main Business Overview
11.2.5 Affymetrix Inc. Latest Developments
11.3 Agilent Technologies Inc
11.3.1 Agilent Technologies Inc Company Information
11.3.2 Agilent Technologies Inc DNA Diagnostics & Testing Product Offered
11.3.3 Agilent Technologies Inc DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Agilent Technologies Inc Main Business Overview
11.3.5 Agilent Technologies Inc Latest Developments
11.4 Applied Biosystems Group
11.4.1 Applied Biosystems Group Company Information
11.4.2 Applied Biosystems Group DNA Diagnostics & Testing Product Offered
11.4.3 Applied Biosystems Group DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Applied Biosystems Group Main Business Overview
11.4.5 Applied Biosystems Group Latest Developments
11.5 Illumina Inc.
11.5.1 Illumina Inc. Company Information
11.5.2 Illumina Inc. DNA Diagnostics & Testing Product Offered
11.5.3 Illumina Inc. DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Illumina Inc. Main Business Overview
11.5.5 Illumina Inc. Latest Developments
11.6 Cepheid Inc.
11.6.1 Cepheid Inc. Company Information
11.6.2 Cepheid Inc. DNA Diagnostics & Testing Product Offered
11.6.3 Cepheid Inc. DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Cepheid Inc. Main Business Overview
11.6.5 Cepheid Inc. Latest Developments
11.7 Hologic
11.7.1 Hologic Company Information
11.7.2 Hologic DNA Diagnostics & Testing Product Offered
11.7.3 Hologic DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Hologic Main Business Overview
11.7.5 Hologic Latest Developments
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Information
11.8.2 Bio-Rad Laboratories DNA Diagnostics & Testing Product Offered
11.8.3 Bio-Rad Laboratories DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bio-Rad Laboratories Main Business Overview
11.8.5 Bio-Rad Laboratories Latest Developments
11.9 Dako
11.9.1 Dako Company Information
11.9.2 Dako DNA Diagnostics & Testing Product Offered
11.9.3 Dako DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Dako Main Business Overview
11.9.5 Dako Latest Developments
11.10 Abbott
11.10.1 Abbott Company Information
11.10.2 Abbott DNA Diagnostics & Testing Product Offered
11.10.3 Abbott DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Abbott Main Business Overview
11.10.5 Abbott Latest Developments
11.11 Roche Diagnostics
11.11.1 Roche Diagnostics Company Information
11.11.2 Roche Diagnostics DNA Diagnostics & Testing Product Offered
11.11.3 Roche Diagnostics DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Roche Diagnostics Main Business Overview
11.11.5 Roche Diagnostics Latest Developments
11.12 Beckman Coulter Inc.
11.12.1 Beckman Coulter Inc. Company Information
11.12.2 Beckman Coulter Inc. DNA Diagnostics & Testing Product Offered
11.12.3 Beckman Coulter Inc. DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Beckman Coulter Inc. Main Business Overview
11.12.5 Beckman Coulter Inc. Latest Developments
11.13 Siemens Healthcare
11.13.1 Siemens Healthcare Company Information
11.13.2 Siemens Healthcare DNA Diagnostics & Testing Product Offered
11.13.3 Siemens Healthcare DNA Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Siemens Healthcare Main Business Overview
11.13.5 Siemens Healthcare Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂